NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 49 filers reported holding NEOS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $143,000 | -11.2% | 229,500 | -24.6% | 0.00% | -25.0% |
Q3 2020 | $161,000 | -33.7% | 304,500 | -14.1% | 0.00% | -20.0% |
Q2 2020 | $243,000 | +85.5% | 354,500 | +102.6% | 0.01% | +66.7% |
Q1 2020 | $131,000 | -58.7% | 175,000 | -16.7% | 0.00% | -25.0% |
Q4 2019 | $317,000 | +1.9% | 210,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $311,000 | +71.8% | 210,000 | +50.0% | 0.00% | +100.0% |
Q2 2019 | $181,000 | -50.4% | 140,000 | 0.0% | 0.00% | -60.0% |
Q1 2019 | $365,000 | +1360.0% | 140,000 | +833.3% | 0.01% | – |
Q4 2018 | $25,000 | -97.0% | 15,000 | -91.2% | 0.00% | -100.0% |
Q3 2018 | $825,000 | +9.9% | 170,100 | +41.6% | 0.01% | 0.0% |
Q2 2018 | $751,000 | -28.6% | 120,100 | -5.3% | 0.01% | -27.3% |
Q1 2018 | $1,052,000 | +67.0% | 126,800 | +105.2% | 0.01% | +57.1% |
Q4 2017 | $630,000 | +25.0% | 61,800 | +12.2% | 0.01% | +16.7% |
Q3 2017 | $504,000 | +25.4% | 55,100 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $402,000 | -30.2% | 55,100 | -31.1% | 0.01% | -28.6% |
Q1 2017 | $576,000 | +23.1% | 80,000 | 0.0% | 0.01% | +16.7% |
Q4 2016 | $468,000 | -11.0% | 80,000 | 0.0% | 0.01% | -25.0% |
Q3 2016 | $526,000 | -12.8% | 80,000 | +23.1% | 0.01% | -11.1% |
Q2 2016 | $603,000 | – | 65,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|